First quarter 2019 results presentation

Operating income, growth figures, profitability and how our products have behaved


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the purchase of Falithrom®, which was owned by Hexal AG (“Hexal”), a company...
1 min
09/01/2019
0 min
06/11/2018